Medpace Recognized as CRO Recipient of the 2026 SCRS Eagle Award
Medpace is honored to announce that we have been awarded the SCRS 2026 CRO Eagle Award, for the second year...
Respiratory Innovation Moves Closer to Disease Modification
In September 2026, Medpace respiratory experts attended the ERS Congress in Barcelona, Spain. As the world’s largest respiratory meeting, the...
Inside AD/PD 2026: Emerging Breakthroughs in Alzheimer’s and Parkinson’s
Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...
Top 5 Breakthroughs in Stroke Research from ISC
Authors: James Vornov MD, PhD and Jessica Yehnert Recently, the Medpace stroke team attended ISC (International Stroke Conference). Among the many presentations, one study in...
Top 3 Key Takeaways from ENCALS 2025
Medpace Medical and Clinical Operations Experts Share Key Insights from the ENCALS Meeting
Highlights from ESCMID Global 2025 and a Look Ahead into the Next Wave of Innovations
Explore insights from Medpace medical and operational experts as they identify key themes from ESCMID Global 2025.
Innovations in Infectious Diseases & Vaccines Clinical Development – Highlights from ESCMID Global 2024
Medpace infectious diseases and vaccines experts share key takeaways from ESCMID Global 2024 in Barcelona, Spain.
Emerging Trends in Hematology – ASH 2023 Highlights
In December 2023, Medpace classic and malignant hematology experts attended the 65th American Hematology Society (ASH) conference in San Diego, CA. Learn more from Blythe…